US and China touch on pharma topics in latest talks
This article was originally published in Scrip
Executive Summary
The focus of the latest round of talks under the US and China's Strategic Economic Dialogue (SED) was not surprisingly on global economic problems, although the discussions also touched on drug safety, the need to support innovation and traditional Chinese medicines.